Data science company IQuity has announced the launch of a new blood test called IsolateFibromyalgia, which uses RNA gene expression analysis to diagnose fibromyalgia, according to a press release.

“RNA analysis is a cutting-edge tool for doctors that has great potential in the field of medical diagnostics,” Chase Spurlock, PhD, CEO of IQuity, said in the release. “Unlike DNA, which can predict the risk of certain diseases, RNA shows what’s taking place right now in a patient’s cells. That information can speed up the pace of diagnosis for physicians, leading to faster, more effective treatment for patients.”

The test, which the company states is 94% accurate, uses a blood sample to test if a patient’s gene expression pattern is consistent with fibromyalgia. Physicians can order the test from and receive results back within 7 days of the laboratory taking delivery of the sample.

Read more of this article in Healio Rheumatology